Adma Biologics reported $238.57M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
Adma Biologics USD 238.57M 238.54M Jun/2025
Alnylam Pharmaceuticals USD 130.98M 129.67M Jun/2025
Dynavax Technologies USD 117.23M 117.11M Jun/2025
Takeda JPY 1.56B 1.69T Jun/2025